
LBBAP lowers AF risk versus RVP in high-pacing patients. The retrospective cohort study (LBBAP: 122, RVP: 166) found LBBAP had a shorter QRS duration (113±22 vs. 140±27ms, p<0.001). Over ~22 months, AF risk was 2.62 times higher in RVP (p=0.014). LBBAP also reduced LVEDD (p=0.002). These findings suggest LBBAP offers superior pacing benefits over RVP in reducing AF progression.
Like
Save
Share